Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

It seems like the medical research community remains largely divided on the issue, with some insisting that cannabis use contributes to mental health condition diagnoses while others suggesting that people with mental health conditions are inherently drawn to cannabis use. Cannabis and Anxiety. CBD for Anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Clinical Trials 192

Clinical Trials Chronic Pain Data Treatment 192

Veriheal

MARCH 20, 2023

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Psilocybin Policies Around the Nation Let’s explore where psilocybin is legal, decriminalized, and on the ballot across U.S.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

The Cannigma

MAY 19, 2021

Medical : Illegal Recreational : Illegal *CBD products are legal in Japan, as long as they contain no THC whatsoever and are not made from cannabis flower. Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. Shutterstock). per milligram.

Law 137

Law Legalization Clinical Trials CBD 137

Cannabis Law Report

JUNE 24, 2022

The leader of the New Jersey Senate filed a bill on Thursday that would legalize the possession, home cultivation and gifting of psilocybin mushrooms for adults 21 and older—with provisions that give adults even more freedoms for the psychedelic than are afforded under the state’s current marijuana laws. Marijuana Moment reports.

Clinical Trials 52

Clinical Trials Legalization Research and Development Therapy 52

Puff Puff Post

JANUARY 1, 2020

One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Cannabis Cancer Treatments as an Alternative to Opioids. Therefore doctors now consider cannabis as the better treatment option. In some cases opiods work better.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Cannabis Law Report

MAY 28, 2022

We have been following the research and development of these medicines for psychiatric conditions such as PTSD and treatment-resistant depression. How does Husch Blackwell intend to assist or guide innovators in the psychedelics industry? Read full article at.

Research and Development 52

Research and Development Therapy Clinical Trials Legalization 52

Cannabis Law Report

MAY 31, 2022

The short answer is: that current legal options (i.e. legal at the state level or the state and federal level) are limited. The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. Federal Legal Status.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Veriheal

AUGUST 22, 2022

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. Quite frankly, the clinical trials couldn’t have come at a better time. About the Opioid Epidemic. According to the 2019 National Survey on Drug Use and Health , an estimated 10.1 Together, they work very well.

Clinical Trials 113

Clinical Trials Chronic Pain Hydroponic Strains 113

Medicinal Marijuana Association

FEBRUARY 11, 2024

You may have heard whispers of cannabis being used to address a specific eye condition, but what does the research truly reveal about its effectiveness? The potential link between cannabis and glaucoma treatment is a topic of ongoing investigation, stirring both curiosity and caution within the medical community.

Treatment 52

Treatment Blood Pressure Conditions Clinical Trials 52

Puff Puff Post

JANUARY 1, 2020

One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Cannabis Cancer Treatments as an Alternative to Opioids. Therefore doctors now consider cannabis as the better treatment option. In some cases opiods work better.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

Cannabis Law Report

FEBRUARY 24, 2022

Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions. Timeline of Medicinal Legalization in Canada. The new exemption reflects the emerging global renaissance of psychedelic treatment.

Therapy 52

Therapy Access Clinical Trials Treatment 52

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. Physician’s Prescription: Patients must obtain a prescription from a qualified physician registered with the TCUP.

Law 52

Law Dispensary Clinical Trials Programs 52

The Cannigma

AUGUST 26, 2021

Medical: Legal Recreational: Illegal (though at least one territory has adopted decriminalization). Australia has a legal medical marijuana program, and while recreational cannabis remains illegal on the federal level, the enforcement of cannabis laws and the penalties handed out can differ widely from one territory to another.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

JUNE 19, 2022

The market for psychedelic substances is projected to grow rapidly, potentially outpacing the legal US cannabis market. For example, compounds such as psilocybin, mescaline, ibogaine, and LSD are being evaluated in clinical trials, but the compounds themselves are unpatentable because their existence is well documented in the prior art.

Clinical Trials 52

Clinical Trials Microdosing Data Pharmaceutical 52

CannaMD

JUNE 2, 2021

Responses came from 49 states, of which 15 had not currently legalized medical marijuana at the time of the study. Of those states that had legalized medical marijuana, 14 currently consider Parkinson’s disease a qualifying condition for medical marijuana therapies. Florida is among these states.

Patients 105

Patients Clinical Trials Treatment Research and Development 105

Canna Care Docs

OCTOBER 3, 2023

Conventional medication methods such as opiates may help terminal patients focus on more palliative treatment options and goals in order to better one’s comfort and overall quality of life during this time. One study from the Journal of Clinical Oncology examined the efficacy of cannabinoids in appetite stimulation.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

The Cannigma

FEBRUARY 2, 2021

Of these consumers, over half said the drug had a beneficial clinical effect on their condition. In light of these results, the researchers behind the survey say that physicians should pay special consideration to these aspects when advising patients on their medical cannabis treatment options. Parkinson’s disease and cannabis.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Canna Law Blog

NOVEMBER 27, 2021

Notwithstanding its dubious distinction as a Schedule I drug, DMT increasingly is the subject of study for its potential efficacy in treating a wide array of mental-health conditions including depression, anxiety, and PTSD. regulators to launch a clinical program to study the use of DMT for the treatment of stroke-related dysfunction.

Therapy 88

Therapy Clinical Trials DEA Microdosing 88

Cannabis Law Report

AUGUST 30, 2021

‘Psychedelic renaissance’ sees first legal collection of Australia’s medicinal magic mushrooms. Key points: This will be Australia’s first legal collection of magic mushrooms. The research could provide the foundation for tailored medical psychedelic treatments. The ABC reports. Psychedelic renaissance.

Clinical Trials 105

Clinical Trials Collective Therapy Treatment 105

The Cannigma

MARCH 7, 2022

CBN’s ability to target CB2 receptors, in comparison to THC (which prefers the CB1 receptor), gives it better credibility in treating autoimmune conditions such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. What can the current clinical trials tell us? Is it even legal? Where can I buy CBN?

THC 140

THC Sleep Clinical Trials Cannabinoids 140

CannaMD

MAY 12, 2021

It’s a favorite cliche of stoner parodies — but one that doesn’t do justice to the potential benefits of medical marijuana for the treatment of eating disorders. The condition can lead to weight gain and obesity. It involves uncontrolled eating beyond the point of feeling full, and often to the point of discomfort.

Marijuana 119

Marijuana Therapy Conditions Food 119

The Joint Blog

FEBRUARY 11, 2022

The legal status of the plant has made the reliable study of the full potential of this amazing compound problematic in the past. With more corners of the world coming around and legalizing the use of CBD for research and treatment of various conditions, a greater understanding of its potential for good is just now becoming apparent.

Clinical Trials 49

Clinical Trials CBD Conditions Data 49

Cannabis Law Report

MAY 19, 2022

When Thomas Hartle indulges in a session of psilocybin treatment, the end-of-life anxiety, distractions and noises associated with his terminal colon cancer go away. “Before the treatment, it’s like you’re sitting in your car. There must have been a lot of treatments done beforehand so the application is solid.”

Therapy 52

Therapy Patients Treatment Clinical Trials 52

PrestoDoctor

OCTOBER 11, 2023

However, with the increasing legalization and the growing awareness of its health benefits, there has been a shift in perception. In this post, we will explore the benefits of CBD-rich cannabis for treating ASD, the science behind it, and how it can help break barriers for individuals with this condition.

CBD 52

CBD Research and Development Clinical Trials Treatment 52

Veriheal

JULY 12, 2021

As a veteran, being able to get past the PTSD involves transitioning out of the mental and emotional war zone, which is challenging and the reason why veterans seek out multiple methods to deal with the condition. At this time, there is little in the way for combat-related PTSD treatment specifically.

Treatment 104

Treatment Sleep Clinical Trials Data 104

Cannabis Law Report

AUGUST 18, 2022

Among the first in the nation, Phillips Lytle’s Psychedelics Practice Team combines expertise in pharmaceutical science, FDA regulations and risk management to serve the legal needs of emerging bio-tech sectors. Promising research in psychedelics as a mental health treatment accelerates growth of industry in need of legal counsel.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

Cannabis Law Report

JANUARY 10, 2022

In addition, rising strategic initiatives by key players in the form of collaborations, clinical trials, and production are further contributing to increasing awareness and adoption of THCV products. Rising clinical trials is thus anticipated to boost the adoption and penetration of rare cannabis derivatives in the forthcoming years.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Key Responsibilities.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

The Cannigma

MARCH 18, 2021

Taken together, the lack of guidance and lack of information about what treatments patients are taking, may underlie “inconsistencies in both use and reported effectiveness,” the researchers stated. Here are the most interesting statistics from the survey. What would be a decisive factor if they were to try medical cannabis?:

Patients 138

Patients Clinical Trials Treatment Cannabis 138

Cannabis Law Report

JULY 4, 2021

CLR contributor, Brian Cusack, writes… The legalization of cannabis in Ireland has become a popular discussion around the world. While countries like Canada, Uruguay, and some states in America have legalized recreational cannabis, this isn’t a trend that has reached Ireland yet. or none at all to qualify with legal status.

THC 105

THC CBD Legalization Oil 105

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

While many critics of medical cannabis continue to debate legalization of cannabis pros and cons, the reality is that the new FDA-approved cannabis drug could reshape how pharmaceutical companies view medical cannabis and encourage them to explore new consumer medical applications of cannabis. Cannabis Legalization Throughout The Country.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Veriheal

JUNE 7, 2021

Note: Veriheal does not support illegally consuming therapeutic substances like MDMA but acknowledges that it transpires because of the current illicit status of both, which we strive to change by advocating for research, legal access, and responsible consumption. Conditions That Could Benefit from MDMA Therapy . What is MDMA?

Therapy 82

Therapy Treatment Conditions Clinical Trials 82

Cannabis Law Report

AUGUST 25, 2021

Lucid has successfully developed a strong pipeline of novel therapeutic compounds — supported by IP in order to advance to future clinical trials — and we are confident that the experience the Lucid leadership team brings will allow us to immediately start the process towards clinical trials to further advance these promising therapies.

Clinical Trials 111

Clinical Trials Research and Development Therapy Conditions 111

Cannabis Law Report

JANUARY 24, 2022

DUBLIN–(BUSINESS WIRE)–The “North America Legal Cannabis Market Size, Share & Trends Analysis Report by Sources (Marijuana, Hemp), by Derivatives (CBD, THC), by End Use (Medical, Recreational), and Segment Forecasts, 2022-2028” report has been added to ResearchAndMarkets.com’s offering. from 2022 to 2028.

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

MMJ Recs

DECEMBER 22, 2023

As the United States navigates through a complex web of legal, social, and medical considerations, public opinion on medical cannabis has evolved significantly over the years. The changing public opinion is evident in the increasing number of states legalizing medical cannabis and the growing support for such measures.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

United Patients Group

JANUARY 8, 2023

Cannabis has been shown to be an effective treatment for a variety of conditions caused by bacteria, viruses and fungi. Many neurological conditions are associated with dysregulation of the ECS (for example: epilepsy, Parkinson’s disease). Cannabis has Antiviral, Antibacterial and Fungal Properties. We Need More Research.

Blood Pressure 108

Blood Pressure Sleep Cannabinoids Clinical Trials 108